Valuation : Krka, d. d.

Market Cap 7.87B 9.14B 7.45B 6.76B 12.67B 873B 12.74B 88.53B 34.04B 444B 34.31B 33.56B 1,403B P/E 2026 *
18.6x
P/E 2027 * 17.7x
Enterprise Value 7.3B 8.47B 6.91B 6.26B 11.75B 809B 11.81B 82.08B 31.56B 412B 31.81B 31.11B 1,301B EV / Sales 2026 *
3.37x
EV / Sales 2027 * 3.14x
Free-Float
74.74%
Yield 2026 *
3.79%
Yield 2027 * 3.98%
1 day-0.38%
1 week-2.26%
Current month-1.14%
1 month+0.19%
6 months+13.54%
Current year+28.08%
1 week 259
Extreme 259
265
1 month 257.5
Extreme 257.5
267
Current year 202
Extreme 202
270
1 year 174
Extreme 174
270
3 years 104
Extreme 104
270
5 years 80
Extreme 80
270
10 years 48.01
Extreme 48.01
270
Manager TitleAgeSince
Chief Executive Officer 71 01/01/2005
Director of Finance/CFO - 01/01/2026
Chief Tech/Sci/R&D Officer - 01/03/2023
Director TitleAgeSince
Director/Board Member 59 01/01/2005
Director/Board Member 59 01/01/2005
Director/Board Member 73 01/01/2010
Change 5-day change 1-year change 3-year change Capi.($)
-0.38%-2.26%+18.18%+139.63% 9.14B
-1.13%-3.11%+13.82%+60.66% 46.21B
-1.13%-5.78%+33.26%+108.13% 38.78B
+0.12%-0.08%+7.12%+78.27% 11.68B
-0.53%-1.37%-13.25%+10.18% 11.55B
+0.32%-2.26%+23.08%+34.73% 7.3B
+0.17%-0.74%+13.44%+197.13% 7.15B
-1.00%-5.25%+34.34%-19.63% 7.1B
-3.13%-4.30%-44.88%+11.66% 4.97B
+0.38%+1.98%+37.00%+105.95% 4.62B
Average -0.63%-2.14%+12.21%+72.67% 14.85B
Weighted average by Cap. -0.82%-3.11%+16.71%+76.60%

Financials

2026 *2027 *
Net sales 2.16B 2.51B 2.05B 1.86B 3.49B 240B 3.5B 24.34B 9.36B 122B 9.44B 9.23B 386B 2.29B 2.66B 2.17B 1.97B 3.69B 254B 3.71B 25.79B 9.92B 129B 10B 9.78B 409B
Net income 430M 499M 407M 369M 693M 47.71B 696M 4.84B 1.86B 24.28B 1.88B 1.83B 76.71B 455M 528M 430M 390M 732M 50.41B 736M 5.11B 1.97B 25.65B 1.98B 1.94B 81.04B
Net Debt -574M -666M -543M -492M -924M -63.61B -928M -6.45B -2.48B -32.36B -2.5B -2.45B -102B -680M -789M -644M -584M -1.1B -75.42B -1.1B -7.65B -2.94B -38.37B -2.96B -2.9B -121B
Logo Krka, d. d.
Krka dd Novo Mesto is a Slovenia-based company engaged in the production of pharmaceutical preparations. The Company operates through four segments: Prescription Pharmaceuticals that includes medicines for the treatment of cardiovascular diseases, alimentary tract and metabolism and drugs for diseases of the central nervous system, among others; Non-prescription Products, providing vitamins and minerals, cough and cold products, analgesics, sore throat products, among others; Animal Health Products, which offers general anti-infectives and antiparasitics for animals; Health Resort and Tourist Services consisting of Spa resorts in Smarjeske Toplice, Dolenjske Toplice, Strunjan, Novo Mesto and Otocec. Krka dd Novo Mesto is a controlling company of the Krka Group that includes two subsidiaries in Slovenia, Terme Krka doo and Farma GRS doo, and over 20 subsidiaries abroad in such countries as Croatia, Germany, Sweden, Poland, Spain, United States, Ireland, among others.
Employees
13,300
Date Price Change Volume
11/09/26 €260.00 -0.38% 4,454
10/09/26 €261.00 0.00% 3,752
09/09/26 €261.00 +0.38% 2,799
08/09/26 €260.00 -0.76% 4,409
07/09/26 €262.00 -1.50% 4,700
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
260.00EUR
Average target price
257.83EUR
Spread / Average Target
-0.83%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KRKG Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!